Vitamin D in human reproduction: A narrative review

International Journal of Clinical Practice

Volumn 67, Issue 3, 2013, Pages 225-235

  Anagnostis, Panagiotis ^a   Karras, Spyridon ^a   Goulis, Dimitrios G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL; MESSENGER RNA; TESTOSTERONE; VITAMIN D;

CLINICAL FEATURE; ENDOMETRIOSIS; FERTILIZATION IN VITRO; GENE EXPRESSION REGULATION; HUMAN; METABOLIC DISORDER; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PUBLICATION; REPRODUCTION; REVIEW; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; SUBFERTILITY; TREATMENT OUTCOME; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

ANIMALS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; FEMALE; FERTILITY; FERTILIZATION IN VITRO; GENITALIA, FEMALE; GENITALIA, MALE; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; POLYCYSTIC OVARY SYNDROME; RECEPTORS, CALCITRIOL; SEMEN ANALYSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84874108338     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12031     Document Type: Review

References (108)

1. Lieben L, Carmeliet G, Masuyama R,. Calcemic actions of vitamin D: effects on the intestine, kidney and bone. Best Pract Res Clin Endocrinol Metab 2011; 25: 561-72.
2. Holick MF,. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
3. Lips P,. Vitamin D physiology. Prog Biophys Mol Biol 2006; 92: 4-8.
4. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW,. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004; 101: 7711-5.
5. Ellfolk M, Norlin M, Gyllensten K, Wikvall K,. Regulation of human vitamin D325-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells. Mol Pharmacol 2009; 75: 1392-9.
6. Henry HL,. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 2011; 25: 531-41.
7. 3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 2007; 103: 316-21.
8. 3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011; 25: 543-59.
9. Nagpal S, Na S, Rathnachalam R,. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-87.
10. Liu PT, Stenger S, Li H, et al., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-3.
11. Mora JR, Iwata M, von Andrian UH,. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685-98.
12. Anagnostis P, Karagiannis A, Kakafika AI, Tziomalos K, Athyros VG, Mikhailidis DP,. Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?. Osteoporos Int 2009; 20: 197-207.
13. 3 in vivo and in vitro. Mol Endocrinol 2004; 18: 2660-71.
14. Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU,. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 2008; 149: 558-64.
15. 2+ concentration in pancreatic beta-cells through nongenomic signal transduction. Endocrinology 1999; 140: 4706-12.
16. Rosen CJ,. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011; 364: 248-54.
17. Anagnostis P, Athyros VG, Adamidou F, Florentin M, Karagiannis A,. Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?. Curr Vasc Pharmacol 2010; 8: 720-30.
18. Melamed ML, Michos ED, Post W, Astor B,. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629-37.
19. Lerchbaum E, Obermayer-Pietsch B,. Vitamin D and fertility-a systematic review. Eur J Endocrinol 2012; 166: 765-78.
20. Grundmann M, von Versen-Höynck F,. Vitamin D-roles in women's reproductive health?. Reprod Biol Endocrinol 2011; 9: 146.
21. Schmidt L,. Social and psychological consequences of infertility and assisted reproduction-what are the research priorities?. Hum Fertil (Camb) 2009; 12: 14-20.
22. Rojansky N, Benshushan A, Meirsdorf S, Lewin A, Laufer N, Safran A,. Seasonal variability in fertilization and embryo quality rates in women undergoing IVF. Fertil Steril 2000; 74: 476-81.
23. Rojansky N, Brzezinski A, Schenker JG,. Seasonality in human reproduction: an update. Hum Reprod 1992; 7: 735-45.
24. Kivela A, Kauppila A, Ylostalo P, Vakkuri O, Leppäluoto J,. Seasonal menstrual and circadian secretions of melatonin, gonadotropins and prolactin in women. Acta Physiol Scand 1988; 132: 321-7.
25. Melin A, Wilske J, Ringertz H, Sääf M,. Seasonal variations in serum levels of 25-hydroxyvitamin D and parathyroid hormone but no detectable change in femoral neck bone density in an older population with regular outdoor exposure. Am Geriatr Soc 2001; 49: 1190-6.
26. Levine RJ, Mathew RM, Chenault CB, et al., Differences in the quality of semen in outdoor workers during summer and winter. N Engl J Med 1990; 323: 12-6.
27. Wehr E, Pilz S, Boehm BO, März W, Obermayer-Pietsch B,. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol (Oxf) 2010; 73: 243-8.
28. 3 receptor in rat reproductive tissues. Histochem Cell Biol 1996; 105: 7-15.
29. Hirai T, Tsujimura A, Ueda T, et al., Effect of 1,25-dihydroxyvitamin d on testicular morphology and gene expression in experimental cryptorchid mouse: testis specific cDNA microarray analysis and potential implication in male infertility. J Urol 2009; 181: 1487-92.
30. Corbett ST, Hill O, Nangia AK,. Vitamin D receptor found in human sperm. Urology 2006; 68: 1345-9.
31. Blomberg Jensen M, Nielsen JE, Jørgensen A, et al., Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod 2010; 25: 1303-11.
32. Walters MR,. 1,25-dihydroxyvitamin D3 receptors in the seminiferous tubules of the rat testis increase at puberty. Endocrinology 1984; 114: 2167-74.
33. Aquila S, Guido C, Perrotta I, Tripepi S, Nastro A, Andò S,. Human sperm anatomy: ultrastructural localization of 1-alpha,25-dihydroxyvitamin D receptor and its possible role in the human male gamete. J Anat 2008; 213: 555-64.
34. Aquila S, Guido C, Middea E, et al., Human male gamete endocrinology: 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism. Reprod Biol Endocrinol 2009; 7: 140.
35. Foresta C, Strapazzon G, De Toni L, et al., Bone mineral density and testicular failure: evidence for a role of vitamin D 25-hydroxylase in human testis. J Clin Endocrinol Metab 2011; 96: E646-52.
36. 3 on alpha-[1-(14)C]MeAIB accumulation in immature rat testis. Steroids 2009; 74: 264-9.
37. 3 and cyclic AMP in cultured human syncytiotrophoblasts. J Steroid Biochem Mol Biol 2007; 103: 90-6.
38. 3 in plasma membrane targets in immature rat testis: ionic channels and gamma-glutamyl transpeptidase activity. Arch Biochem Biophys 2011; 515: 46-53.
39. Akerstrom VL, Walters MR,. Physiological effects of 1,25-dihydroxyvitmin D3 in TM4 Sertoli cell line. Am J Physiol Endocrinol Metab 1992; 262: E884-90.
40. Menegaz D, Barrientos-Duran A, Kline A, et al., 1-alpha,25(OH)2-Vitamin D3 stimulation of secretion via chloride channel activation in Sertoli cells. J Steroid Biochem Mol Biol 2010; 119: 127-34.
41. 3 and Ajuga iva extract on oxidative stress, toxicity and hypo-fertility in diabetic rat testes. J Physiol Biochem 2008; 64: 231-9.
42. 2+-binding proteins parvalbumin, calbindin D-28K, S-100 proteins and calmodulin during testicular development in the rat. Cell Tissue Res 1988; 252: 359-65.
43. Inpanbutr N, Reiswig JD, Bacon WL, Slemons RD, Iacopino AM,. Effect of vitamin D on testicular CaBP28K expression and serum testosterone in chickens. Biol Reprod 1996; 54: 242-8.
44. Shahbazi M, Jeddi-Tehrani M, Zareie M, et al., Expression profiling of vitamin D receptor in placenta, decidua and ovary of pregnant mice. Placenta 2011; 32: 657-64.
45. Parikh G, Varadinova M, Suwandhi P, et al., Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm Metab Res 2010; 42: 754-7.
46. 3 receptor is expressed in the endometrium of cycling mice throughout the estrous cycle. Fertil Steril 2010; 93: 2738-43.
47. 3 24-hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells. J Steroid Biochem Mol Biol 2004; 89-90: 115-9.
48. Tuan RS, Moore CJ, Brittingham JW, Kirwin JJ, Akins RE, Wong M,. In vitro study of placental trophoblast calcium uptake using JEG-3 human choriocarcinoma cells. J Cell Sci 1991; 98: 333-42.
49. 3. Endocrinology 1994; 135: 2651-6.
50. Barrera D, Avila E, Hernández G, et al., Calcitriol affects hCG gene transcription in cultured human syncytiotrophoblasts. Reprod Biol Endocrinol 2008; 6: 3.
51. Belkacemi L, Gariépy G, Mounier C, Simoneau L, Lafond J,. Expression of calbindin-D28k (CaBP28k) in trophoblasts from human term placenta. Biol Reprod 2003; 68: 1943-50.
52. Kinuta K, Tanaka H, Moriwake T, et al., Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 2000; 141: 1317-24.
53. Wojtusik J, Johnson PA,. Vitamin D regulates anti-mullerian hormone expression in granulosa cells of the hen. Biol Reprod 2012; 86: 91.
54. Echchgadda I, Song CS, Roy AK, Chatterjee B,. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 2004; 65: 720-9.
55. Somjen D, Katzburg S, Stern N, et al., 25-hydroxy-vitamin D(3)-1-alpha hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone. J Steroid Biochem Mol Biol 2007; 107: 238-44.
56. Kwiecinski GG, Petrie GI, DeLuca HF,. Vitamin D is necessary for reproductive functions of the male rat. J Nutr 1989; 119: 741-4.
57. Uhland AM, Kwiecinski GG, DeLuca HF,. Normalization of serum calcium restores fertility in vitamin D-deficient male rats. J Nutr 1992; 122: 1338-44.
58. Sood S, Marya RK, Reghunandanan R, Singh GP, Jaswal TS, Gopinathan K,. Effect of vitamin D deficiency on testicular function in the rat. Ann Nutr Metab 1992; 36: 203-8.
59. Yoshizawa T, Handa Y, Uematsu Y, et al., Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997; 16: 391-6.
60. Halloran BP, DeLuca HF,. Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J Nutr 1980; 110: 1573-80.
61. Panda DK, Miao D, Tremblay ML, et al., Targeted ablation of the 25-hydroxyvitamin D 1-alpha hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 2001; 98: 7498-503.
62. 3-deficient mice results from indirect effect mediated by extracellular calcium and/or phosphorus. Am J Physiol Endocrinol Metab 2010; 299: E928-35.
63. Johnson LE, DeLuca HF,. Vitamin D receptor null mutant mice fed high levels of calcium are fertile. J Nutr 2001; 131: 1787-91.
64. Kwiecinksi GG, Petrie GI, DeLuca HF,. 1,25-Dihydroxyvitamin D3 restores fertility of vitamin D-deficient female rats. Am J Physiol 1989; 256: E483-7.
65. Blomberg Jensen M, Bjerrum PJ, Jessen TE, et al., Vitamin D is positively associated with sperm motility and increases intracellular calcium in human spermatozoa. Hum Reprod 2011; 26: 1307-17.
66. Ramlau-Hansen CH, Moeller UK, Bonde JP, Olsen J, Thulstrup AM,. Are serum levels of vitamin D associated with semen quality? Results from a cross-sectional study in young healthy men. Fertil Steril 2011; 95: 1000-4.
67. Lee DM, Tajar A, Pye SR, et al., EMAS study group. Association of hypogonadism with vitamin D status: the European Male Ageing Study. Eur J Endocrinol 2012; 166: 77-85.
68. Nimptsch K, Platz EA, Willett WC, Giovannucci E,. Association between plasma 25-OH vitamin D and testosterone levels in men. Clin Endocrinol (Oxf) 2012; 77: 106-12.
69. Pilz S, Frisch S, Koertke H, et al., Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res 2011; 43: 223-5.
70. 3 analog for the potential treatment of benign prostatic hyperplasia, overactive bladder and male infertility. Idrugs 2009; 12: 381-93.
71. Berkkanoglu M, Arici A,. Immunology and endometriosis. Am J Reprod Immunol 2003; 50: 48-59.
72. Agic A, Xu H, Altgassen C, et al., Relative expression of 1,25-dihydroxyvitamin D3receptor, vitamin D 1-alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci 2007; 14: 486-97.
73. Vigano P, Lattuada D, Mangioni S, et al., Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol 2006; 36: 415-25.
74. Christofolini DM, Barbosa CP,. Analysis of vitamin D receptor gene polymorphisms in women with and without endometriosis. Hum Immunol 2011; 72: 359-63.
75. Proal AD, Albert PJ, Marshall TG,. Dysregulation of the vitamin D nuclear receptor may contribute to the higher prevalence of some autoimmune diseases in women. Ann N Y Acad Sci 2009; 1172: 252-9.
76. Zelenko Z, Aghajanova L, Irwin JC, Giudice LC,. Nuclear receptor, co regulator signalling, and chromatin remodelling pathways suggest involvement of the epigenome in the steroid hormone response of endometrium and abnormalities in endometriosis. Reprod Sci 2012; 19: 152-62.
77. Hartwell D, R¢dbro P, Jensen SB, Thomsen K, Christiansen C,. Vitamin D metabolites-relation to age, menopause and endometriosis. Scand J Clin Lab Invest 1990; 50: 115-21.
78. Somigliana E, Panina-Bordignon P, Murone S, et al., Vitamin D reserve is higher in women with endometriosis. Hum Reprod 2007; 22: 2273-8.
79. Ferrero S, Gillott DJ, Anserini P, et al., Vitamin D binding protein in endometriosis. J Soc Gynecol Investig 2005; 12: 272-7.
80. Borkowski J, Gmyrek GB, Madej JP, et al., Serum and peritoneal evaluation of vitamin D-binding protein in women with endometriosis. Postepy Hig Med Dosw 2008; 62: 103-11.
81. Faserl K, Golderer G, Kremser L, et al., Polymorphismin vitamin D-binding protein as a genetic risk factor in the pathogenesis of endometriosis. J Clin Endocrinol Metab 2011; 96: E233-41.
82. Cho S, Choi YS, Yim SY, et al., Urinary vitamin D-binding protein is elevated in patients with endometriosis. Hum Reprod 2012; 27: 515-22.
83. Ozkan S, Jindal S, Greenseid K, et al., Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril 2010; 94: 1314-9.
84. Anifandis GM, Dafopoulos K, Messini CI, et al., Prognostic value of follicular fluid 25-OH vitamin D and glucose levels in the IVF outcome. Reprod Biol Endocrinol 2010; 8: 91.
85. Aleyasin A, Hosseini MA, Mahdavi A, et al., Predictive value of the level of vitamin D in follicular fluid on the outcome of assisted reproductive technology. Eur J Obstet Gynecol Reprod Biol 2011; 159: 132-7.
86. Qiao J, Feng HL,. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 2011; 17: 17-33.
87. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R,. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011; 7: 219-31.
88. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG,. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011; 94: 486-94.
89. George PS, Pearson ER, Witham MD,. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 2012; 29: e142-50.
90. Panidis D, Balaris C, Farmakiotis D, et al., Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem 2005; 51: 1691-7.
91. Hahn S, Haselhorst U, Tan S, et al., Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006; 114: 577-83.
92. Wehr E, Pilz S, Schweighofer N, et al., Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 2009; 161: 575-82.
93. Yildizhan R, Kurdoglu M, Adali E, et al., Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009; 280: 559-63.
94. Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK,. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 2011; 60: 1475-81.
95. Mahmoudi T, Gourabi H, Ashrafi M, Yazdi RS, Ezabadi Z,. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril 2010; 93: 1208-14.
96. Muscogiuri G, Policola C, Prioletta A, et al., Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?. Clin Nutr 2012; 31: 476-80.
97. Dunaif A, Segal KR, Futterweit W, Dobrjansky A,. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165-74.
98. Ott J, Wattar L, Kurz C, et al., Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study. Eur J Endocrinol 2012; 166: 897-902.
99. Savastano S, Valentino R, Di Somma C, et al., Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS. Nutr Metab (Lond) 2011; 8: 84.
100. Mazloomi S, Sharifi F, Hajihosseini R, Kalantari S, Mazloomzadeh S,. Association between hypoadiponectinemia and low serum concentrations of calcium and vitamin D in women with polycystic ovary syndrome. ISRN Endocrinol 2012; 2012: 949427.
101. Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer-Pietsch B,. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 2011; 164: 741-9.
102. Mahmoudi T,. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril 2009; 92: 1381-3.
103. Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian JP,. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroid 1999; 64: 430-5.
104. Rashidi B, Haghollahi F, Shariat M, Zayerii F,. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol 2009; 48: 142-7.
105. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG,. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 2009; 92: 1053-8.
106. Obermayer-Pietch B,. Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. J Endocrinol Invest 2011; 34: 757-63.
107. Selimoglu H, Duran C, Kiyici S, et al., The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 2010; 33: 234-8.
108. Ardabili HR, Gargari BP, Farzadi L,. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res 2012; 32: 195-201.